http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2518350-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8ef3e55c88b441e9759d107f6d9483d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff2c2d96aeb635dc20d5db22f430f76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64d558f75d9e8e89fcced9d0a6001c95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c16b0586d32114b3332b012d129c035 |
| publicationDate | 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2518350-C2 |
| titleOfInvention | Differential diagnostic technique for benign and malignant nonpigmented skin growth |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine. According to the method, 3 hours after oral administration of the preparation Alasens 15 mg/kg of the body weight, a three-channel RGB fluorescence imaging of a zone of interest is formed. A part of the red channel in the tumour imaging is estimated. The value R cut =(R/(R+G+B))ยท100% is calculated, wherein R cut is the part of the red channel in the tumour imaging, R, G and B are the brightness values of the red, green and blue channels of the intact skin. The formed three-channel RGB fluorescence imaging is used to create a grey shade imaging l(x,y). The relation I 1 ( x , y ) = R ( x , y ) R ( x , y ) + G ( x , y ) + B ( x , y ) โ 100 % n is calculated for each imaging point I(x,y), wherein R(x,y), G(x,y), B(x,y) are the brightness values of the red, green and blue channels RGB of the fluorescent imaging with the coordinates x, y. The operation I(x,y)=0 is carried out for the points wherein the value [ I 1 ( x , y ) โ R c u t R c u t โ 100 % ] n is less than 10%. If the tumour is displayed in the derived result imaging l(x,y), it is diagnosed as malignant, while the benign tumour tends to disappear from the imaging. n EFFECT: method enables providing higher information value ensured by more accurate imaging of the malignant tumour borders. n 1 ex |
| priorityDate | 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.